Home19X • FRA
add
Axsome Therapeutics Inc
Previous close
€115.80
Day range
€116.25 - €116.25
Year range
€70.00 - €135.55
Market cap
6.65B USD
Avg Volume
24.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 150.04M | 72.13% |
Operating expense | 181.41M | 17.04% |
Net income | -47.97M | 39.54% |
Net profit margin | -31.97 | 64.88% |
Earnings per share | -0.97 | 41.92% |
EBITDA | -42.57M | 42.39% |
Effective tax rate | 1.96% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 303.02M | -4.00% |
Total assets | 639.78M | 16.70% |
Total liabilities | 566.71M | 27.24% |
Total equity | 73.08M | — |
Shares outstanding | 49.90M | — |
Price to book | 78.78 | — |
Return on assets | -18.12% | — |
Return on capital | -40.39% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -47.97M | 39.54% |
Cash from operations | -32.42M | -7.68% |
Cash from investing | -13.00K | 75.00% |
Cash from financing | 34.54M | 140.24% |
Net change in cash | 2.11M | 113.34% |
Free cash flow | -15.18M | -364.31% |
About
Founded
2012
Website
Employees
846
